help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fleming, W. H.
Right arrow Articles by Friesen, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fleming, W. H.
Right arrow Articles by Friesen, H. G.

Endocrinology, Vol 117, 2547-2549, Copyright © 1985 by Endocrine Society


ARTICLES

Human growth hormone induces and maintains c-myc gene expression in Nb2 lymphoma cells

WH Fleming, PR Murphy, LJ Murphy, TW Hatton, RJ Matusik and HG Friesen

The effect of human GH (hGH) on c-myc gene expression and cell proliferation in the Nb2 lymphoma cell line was examined. The addition of hormone to stationary cultures of Nb2 cells resulted in an increased accumulation of c-myc transcripts that was detectable within 15 min, reached a maximum induction of 25-fold in 3 h, and then gradually declined. Although maximal accumulation of c-myc transcripts occurred within 3 h after hGH addition, removal of the hormone even after 4 h of treatment resulted in a failure of the cells to proliferate. This loss of proliferative capacity following hormone removal was accompanied by a 20-fold reduction in the level of c-myc transcripts. These results indicate that hGH induced proliferation of Nb2 cells is associated with the induction and maintenance of c-myc gene expression.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. Giustina, M. Gola, M. Doga, and E. A. Rosei
Primary Lymphoma of the Pituitary: An Emerging Clinical Entity
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4567 - 4575.
[Full Text] [PDF]


Home page
EndocrinologyHome page
S. Jeay, G. E. Sonenshein, P. A. Kelly, M.-C. Postel-Vinay, and E. Baixeras
Growth Hormone Exerts Antiapoptotic and Proliferative Effects through Two Different Pathways Involving Nuclear Factor-{{kappa}}B and Phosphatidylinositol 3-Kinase
Endocrinology, January 1, 2001; 142(1): 147 - 156.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society